Metabolic signatures for gastric cancer diagnosis and mechanistic insights: a multicenter study.
This study addresses the critical need for improved early detection of gastric cancer (GC) by developing a non-invasive...
Integrating immunotherapy into chemotherapy: real-world efficacy of GEMOX plus Tislelizumab in advanced gallbladder cancer.
- Post category:Digestive (CRC, Stomach) System
- Reading time:1 min read
This study evaluated the efficacy of GEMOX chemotherapy combined with Tislelizumab versus GEMOX alone in 150 patients wi...
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial.
- Post category:Digestive (CRC, Stomach) System
- Reading time:1 min read
This multicenter, randomized phase 2/3 trial evaluated the use of circulating tumor DNA (ctDNA) to guide adjuvant chemot...
Quality Indicators for Screening and Surveillance of Colorectal Cancer in Adults: A Review of Performance Measures by the American College of Physicians.
- Post category:Digestive (CRC, Stomach) System
- Reading time:1 min read
Colorectal cancer is a leading cause of cancer-related deaths, and screening effectively reduces morbidity and mortality...
Pembrolizumab Plus Chemotherapy Versus Chemotherapy as Perioperative Therapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer: Final Analysis of the Randomized, Phase III KEYNOTE-585 Study.
- Post category:Digestive (CRC, Stomach) System
- Reading time:1 min read
The phase III KEYNOTE-585 trial evaluated neoadjuvant and adjuvant pembrolizumab combined with chemotherapy versus chemo...
Prolonged response to dual immune checkpoint blockade in patients with advanced solid tumors: a case series.
- Post category:Digestive (CRC, Stomach) System
- Reading time:1 min read
This publication reports on five patients with advanced cancers—ranging from microsatellite stable rectal and colon ad...